Skip to content
Abierto
Menu

Award notice

PREVENT Cancer Preclinical Drug Development Program: Toxicology and Pharmacology Testing

75N91024D00002

National Institutes of Health, NIH NCI. Research and Development in Biotechnology (except Nanobiotechnology).

View on SAM.govMarkdown

Awarded

University of Illinois

$149,995,000.00 on the award notice, January 23, 2024, contract 75N91024D00002

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

Recipient
University of Illinois
UEI
W8XEAJDKMXH3
CAGE
1YGW1
Vendor location
Chicago, IL
Contract
75N91024D00002
Obligated
$0.00, potential $149,995,000
Actions
4 between January 23, 2024 and January 31, 2025
Competition
Full and Open Competition, 9 offers received
Set-aside reported
No Set Aside Used.
Described as
Prevent Cancer Preclinical Drug Development Program: Toxicology and Pharmacology Testing
Match
award number 75N91024D00002 equals the contract number; same awarding office 75N910 (high confidence)
Record
USAspending award page

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. January 23, 2024

    Award notice, originally solicitation

    PREVENT IDIQ MATO RFP

    Awarded to University of Illinois Chicago for $149,995,000. SAM.gov, notice 1ac42dbbd11b43bf8e104d7e959fee9d

  2. January 23, 2024

    Award notice

    Awarded to University of Illinois Chicago for $149,995,000. SAM.gov, notice d411ff3d78964c52be53e0e61e3091fc

Points of contact

Also open from this buyer